BungeEMHoetBChenL, et al.The changing epidemiology of human monkeypox-A potential threat?A System Rev2022; 16: e0010141.
2.
KumarNAcharyaAGendelmanHE, et al.The 2022 outbreak and the pathobiology of the monkeypox virus. J Autoimmun2022; 131: 102855.
3.
AbdelaalSerhanMahmoud , et al.Ophthalmic manifestations of monkeypox virus. Eye (Lond)2023 Feb; 37: 383–385.
4.
PetersenEKanteleAKoopmansM, et al.Human monkeypox: epidemiologic and clinical characteristics, diagnosis, and prevention. Infect Dis Clin North Am2019 Dec; 33: 1027–1043.
5.
GandhiAPGuptaPCPadhiBK, et al.Ophthalmic manifestations of the monkeypox virus: a systematic review and meta-analysis. Pathogens2023 Mar 14; 12: 452.
6.
HughesCMcCollumAPukutaE, et al.Ocular complications associated with acute monkeypox virus infection, DRC. Int J Infect Dis2014; 21: 276–277.
7.
Ly-YangFMiranda-SánchezABurgos-BlascoB, et al.Conjunctivitis in an individual with monkeypox. JAMA Ophthalmol2022; 140: 1022–1024.
JežekZSzczeniowskiMPalukuK, et al.Human monkeypox: clinical features of 282 patients. J Infect Dis1987; 156: 293–298.
10.
VogelL. Making sense of monkeypox death rates. C Can Med Assoc J2022; 194: E1097.
11.
ShamimMAPadhiBKSatapathyP, et al.The use of antivirals in the treatment of human monkeypox outbreaks: a systematic review: antivirals in treatment of monkeypox: systematic review. Int J Infect Dis2022; 127: 150–161.
